Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
AstraZeneca Plc, Medical Equipment, Deal Details 14
Venture Financing 14
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
Partnerships 19
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
Merger 42
AstraZeneca Rumored To Merge With Amgen 42
Debt Offering 43
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Acquisition 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc – Key Competitors 52
Key Employees 53
Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 61
Strategy And Business Planning 61
Apr 04, 2016: Heptares Joins Pharma Consortium Applying State of the Art Cryo-Electron Microscopy to Advance Structure Based Drug Discovery 61
Financial Announcements 62
Feb 02, 2017: Astrazeneca Announces Full-Year and Q4 2016 Results 62
Nov 10, 2016: AstraZeneca: Year-To-Date and Q3 2016 Results 63
Jul 28, 2016: AstraZeneca: H1 2016 Results 75
Apr 29, 2016: AstraZeneca announces 1st Quarter 2016 Results 86
Apr 29, 2016: AstraZeneca Announces Q1 2016 Results 97
Feb 04, 2016: Full-Year and Q4 2015 Results 99
Feb 04, 2016: AstraZeneca Full-Year and Q4 2015 Results 101
Corporate Communications 114
Nov 09, 2016: Change To Astrazeneca Board Of Directors 114
Sep 28, 2016: Change To Astrazeneca Board Of Directors 115
Other Significant Developments 116
Sep 21, 2016: AstraZeneca Selects LLamasoft as Supply Chain Design Partner of Choice 116
Appendix 117
Methodology 117
About GlobalData 117
Contact Us 117
Disclaimer 117
AstraZeneca Plc, Medical Equipment, Key Facts, 2015 1
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Deals By Market, 2011 to YTD 2017 10
AstraZeneca Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 11
Definiens Raises USD20.3 Million in Venture Financing Round 14
CeraPedics Raises US$19 Million In Series C Financing 15
Definiens Raises US$13 Million In Venture Financing 16
Ambit Biosciences Secures US$30 Million In Series D-2 Financing 17
AstraZeneca Enters into Agreement with Genedata 19
Neoprobe Enters Into Licensing Agreement With AstraZeneca 20
AgPlus Diagnostics Enters into Agreement with AstraZeneca 21
Indivumed Partners with Definiens 22
Foundation Medicine Enters into Agreement with AstraZeneca 23
MedImmune Enters into Agreement with Genisphere 23
Definiens Partners with MolecularMD 24
Human Longevity Partners with AstraZeneca 25
PROOF Centre Partners with AstraZeneca 26
Labcyte Enters into Agreement with AstraZeneca 26
HighRes Biosolutions Enters into Agreement with AstraZeneca 27
AstraZeneca Enters into Research Agreement with Sutter Health 28
Myriad Genetics Expands Agreement with AstraZeneca 29
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 30
AstraZeneca Enters into Co-Development Agreement with Qiagen 31
AstraZeneca Enters into Co-Development Agreement with Roche 32
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 32
Ventana Medical Enters into Co-Development Agreement with MedImmune 33
Definiens Enters Into Agreement With Metamark For ProMark Prognostic Test 34
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 35
Oxford Cancer Biomarkers Enters Into Agreement With AstraZeneca For Biomarker Discovery 36
AstraZeneca Enters Into Research Agreement With Karolinska Institutet 36
Metamark Genetics Enters Into Co-Development Agreement With Definiens 37
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement 38
Leica Microsystems Enters Into Co-Marketing Agreement With Definiens 39
Definiens Enters Into An Agreement With Cernostics 40
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 41
AstraZeneca Rumored To Merge With Amgen 42
AstraZeneca Prices Private Placement of 0.875% Notes Due 2021 43
Pfizer May Increase Bid to Acquire AstraZeneca 43
MedImmune Acquires Definiens for USD150 Million 45
AstraZeneca Rumored To Acquire Forest Labs For US$15 Billion 46
Celltrion Chairman Jung Jin Seo Plans To Sell Controlling Stake In The Company 47
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 48
DENTSPLY International Acquires Astra Tech From AstraZeneca For US$1,800 Million 49
AstraZeneca Plc, Key Competitors 52
AstraZeneca Plc, Key Employees 53
AstraZeneca Plc, Subsidiaries 55
List of Figures
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
AstraZeneca Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 7
AstraZeneca Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 8
AstraZeneca Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 9
AstraZeneca Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 10